Medication info
Empagazamet Tablet 5/850 mg (Empagliflozin 2L-Proline, Metformin)

Empagazamet Tablet 5/850 mg (Empagliflozin 2L-Proline, Metformin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin 2L-Proline›7.55mg / 1 tabletMetformin Hydrochloride›850mg / 1 tablet
Manufacturer / importer
Kyungbo Pharmaceutical Co., Ltd.
Appearance
Oval film-coated tablet with a white color with a yellowish tint
Packaging
30 tablets/bottle, 60 tablets/bottle
Approval status
Active

MFDS item code 202502921 · Approved 2025.11.12

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medication is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medications such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and their current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medication from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medication is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Drug Interactions under Precautions for Use). This medication should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medication contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with empagliflozin and metformin as separate single-ingredient products. The maximum daily dose of metformin hydrochloride that may be administered with this medication is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see section 3. Patients Requiring Caution under Precautions for Use, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medication should be discontinued immediately (see section 2. Patients Who Must Not Take This Medication under Precautions for Use, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Kyungbo Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Blood glucose control problems in adults with type 2 diabetes
  • cardiovascular disease
  • risk of occurrence of cardiovascular events
View approved original text

This medication helps improve blood glucose control in adults with type 2 diabetes when used in combination with empagliflozin and metformin. It is administered as an adjunct to diet and exercise therapy for patients whose blood glucose is not adequately controlled, and it is particularly effective for those patients. Additionally, caution is advised for adults with type 2 diabetes and cardiovascular disease regarding the occurrence of cardiovascular events, and the directions of professionals must be closely followed. This medication is used to enhance blood glucose management and is utilized in the treatment of diabetes.

How to take

Adult dose

The recommended dose of this medication is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medications such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and their current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medication from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medication is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Drug Interactions under Precautions for Use). This medication should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medication contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with empagliflozin and metformin as separate single-ingredient products. The maximum daily dose of metformin hydrochloride that may be administered with this medication is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see section 3. Patients Requiring Caution under Precautions for Use, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medication should be discontinued immediately (see section 2. Patients Who Must Not Take This Medication under Precautions for Use, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Precautions

This medication assists in lowering blood glucose and is used for diabetes treatment. However, it can cause a rare complication called severe lactic acidosis, which requires caution. Lactic acidosis is a dangerous condition where lactic acid accumulates excessively in the body, which can lead to death. Additionally, when taken in conjunction with other diabetes medications such as insulin or sulfonylureas, hypoglycemia may occur, so care should be taken. This medication should not be used in patients with severe renal impairment or in patients with acute infections, heart problems, or liver function disorders. It is also safer for women who are pregnant or breastfeeding not to take this medication. Before taking the medication, renal function must be checked, and regular blood tests should be conducted to monitor kidney status. Consult a doctor immediately if dehydration or severe vomiting, diarrhea occurs while taking the medication. This medication may increase the risk of urinary tract infections or genital infections, so quick treatment is necessary if any infection symptoms emerge. Additionally, it may lower vitamin B12 levels, so it is advisable to check blood levels while taking it for an extended period. Alcohol consumption can increase the risk of lactic acidosis, so it is best to avoid it. If surgery is approaching or undergoing tests using iodine contrast agents, the medication should be paused for a certain period, and it should be restarted only after confirming normal renal function. Elderly patients or those at risk of fluid volume loss should take greater care when taking this medication, and immediate measures should be taken if hypoglycemic symptoms arise. In case of overdose, serious side effects such as lactic acidosis may occur, so take exactly as prescribed by your doctor. Regular check-ups and symptom observation are very important while taking this medication.

Side effects

  • Hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
Show 193 more
  • abnormal liver function tests
  • hepatitis
  • taste disturbance
  • pruritus
  • rash
  • urticaria
  • erythema
  • angioedema
  • difficulty urinating
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased blood creatinine
  • decreased glomerular filtration rate
  • reduced and deficient vitamin B12
  • ketoacidosis
  • lactic acidosis
  • decreased fluid volume
  • necrotizing fasciitis of the perineum
  • vulvovaginal candidiasis
  • vulvitis
  • balanitis
  • pyelonephritis
  • urosepsis
  • rash
  • urticaria
  • angioedema
  • chronic gastritis
  • cerebral infarction
  • soft tissue infection
  • pneumonia
  • ankle fracture
  • tendinitis
  • facial bone fracture
  • musculoskeletal pain
  • myocardial infarction
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • lower gastrointestinal bleeding
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pulmonary tuberculosis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • headache
  • sensory loss
  • orthostatic dizziness
  • dizziness
  • weakness
  • chest discomfort
  • chest pain
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • weight loss
  • urinary stones
  • vulvar pruritus
  • benign prostatic hyperplasia
  • diabetic retinopathy
  • double vision
  • hypertension
  • insomnia
  • anxiety
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • otalgia
  • orthostatic vertigo
  • vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • diabetic foot
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • ocular discomfort
  • conjunctival hyperemia
  • pathologic myopia
  • retinal detachment
  • retinal deposits
  • retinal vein occlusion
  • retinal detachment with holes
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • cough
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • road traffic accident
  • splenic injury
  • sternal fracture
  • angina
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral arterial occlusive disease
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • cervical inflammation
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • hyperglycemia
  • hyponatremia
  • dyslipidemia
  • decreased appetite
  • polydipsia
  • drowsiness
  • CNS-derived vertigo
  • memory impairment
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • sensory disturbance
  • drowsiness
  • facial paralysis
  • amnesia
  • carotid stenosis
  • diabetic neuropathy
  • intracranial aneurysm
  • weight gain
  • electrocardiogram abnormalities
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urine red blood cells
  • ureteral stones
  • acute kidney injury
  • chronic kidney disease
  • hematuria
  • overactive bladder
  • renal masses
  • urinary retention
  • urinary pain
  • abnormal urination
  • cervical inflammation
  • unstable angina
  • anxiety
  • sleep disorders

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. This will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

Oval film-coated tablet with a white color with a yellowish tint

Package unit

30 tablets/bottle, 60 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.